ABSTRACT
Alcohol-induced pancreas damage remains as one of the main risk factors for pancreatitis development. This disorder is poorly understood, particularly the effect of acetaldehyde, the primary alcohol metabolite, in the endocrine pancreas. Hepatocyte growth factor (HGF) is a protective protein in many tissues, displaying antioxidant, antiapoptotic, and proliferative responses. In the present work, we were focused on characterizing the response induced by HGF and its protective mechanism in the RINm5F pancreatic cell line treated with ethanol and acetaldehyde. RINm5F cells were treated with ethanol or acetaldehyde for 12 h in the presence or not of HGF (50 ng/ml). Cells under HGF treatment decreased the content of reactive oxygen species and lipid peroxidation induced by both toxics, improving cell viability. This effect was correlated to an improvement in insulin expression impaired by ethanol and acetaldehyde. Using a specific inhibitor of Erk1/2 abrogated the effects elicited by the growth factor. In conclusion, the work provides mechanistic evidence of the HGF-induced-protective response to the alcohol-induced damage in the main cellular component of the endocrine pancreas.
Subject(s)
Acetaldehyde , Ethanol , Acetaldehyde/toxicity , Acetaldehyde/metabolism , Cell Line , Ethanol/toxicity , Hepatocyte Growth Factor , Pancreas/metabolism , MAP Kinase Signaling SystemABSTRACT
The growth differentiation factor 11 (GDF11), a member of the superfamily of the transforming growth factor ß, has gained relevance in the last few years due to its remarkable effects in cellular biology, particularly in the nervous system, skeletal muscle, the heart, and many epithelial tissues. Some controversies have been raised about this growth factor. Many of them have been related to technical factors but also the nature of the cellular target. In liver biology and pathobiology, the GDF11 has shown to be related in many molecular aspects, with a significant impact on the physiology and the initiation and progression of the natural history of liver diseases. GDF11 has been involved as a critical regulator in lipid homeostasis, which, as it is well known, is the first step in the progression of liver disease. However, also it has been reported that the GDF11 is involved in fibrosis, senescence, and cancer. Although there are some controversies, much of the literature indicates that GDF11 displays effects tending to solve or mitigate pathological states of the liver, with reasonable evidence of correlation with other organs or systems. To a large extent, the controversy, as mentioned, is due to technical problems, such as the specificity of GDF11 antibodies, confusion with its closer family member, myostatin, and the state of differentiation in the tissues. In the present work, we reviewed the specific effects of GDF11 in the biology and pathobiology of the liver as a potential and promising factor for therapeutic intervention shortly.
Subject(s)
Growth Differentiation Factors , Muscle, Skeletal , Growth Differentiation Factors/metabolism , Growth Differentiation Factors/pharmacology , Muscle, Skeletal/metabolism , Heart , Liver/metabolismABSTRACT
Cancer cells are characterized by accelerated proliferation and an outstanding adaptation of their metabolic pathways to meet energy demands. The folate cycle, also known as folate metabolism or one-carbon metabolism, through enzymatic interconversions, provides metabolites necessary for nucleotide synthesis, methylation, and reduction power, helping to maintain the high rate of proliferation; therefore, the study of this metabolic pathway is of great importance in the study of cancer. Moreover, multiple enzymes involved in this cycle have been implicated in different types of cancer, corroborating the cell's adaptations under this pathology. During the last decade, nonalcoholic fatty liver disease has emerged as the leading etiology related to the rise in the incidence and deaths of hepatocellular carcinoma. Specifically, cholesterol accumulation has been a determinant promoter of tumor formation, with solid evidence that an enriched-cholesterol diet plays a crucial role in accelerating the development of an aggressive subtype of hepatocellular carcinoma compared to other models. In this review, we will discuss the most recent findings to understand the contribution of folate metabolism to cancer cells and tumor microenvironment while creating a link between the dynamics given by cholesterol and methylenetetrahydrofolate dehydrogenase 1-like, a key enzyme of the cycle located in the mitochondrial compartment.
Subject(s)
Carcinoma, Hepatocellular , Liver Neoplasms , Humans , Carcinoma, Hepatocellular/pathology , Methylenetetrahydrofolate Dehydrogenase (NADP)/metabolism , Liver Neoplasms/pathology , Folic Acid/metabolism , Mitochondria/metabolism , Mitochondria/pathology , Tumor MicroenvironmentABSTRACT
Cadmium is a toxic element to which man can be exposed at work or in the environment. Cd's most salient toxicological property is its exceptionally long half-life in the human body. Once absorbed, Cd accumulates in the human body, particularly in the liver. The cellular actions of Cd are extensively documented, but the molecular mechanisms underlying these actions are still not resolved. The liver manages the cadmium to eliminate it by a diverse mechanism of action. Still, many cellular and physiological responses are executed in the task, leading to worse liver damage, ranging from steatosis, steatohepatitis, and eventually hepatocellular carcinoma. The progression of cadmium-induced liver damage is complex, and it is well-known the cellular response that depends on the time in which the metal is present, ranging from oxidative stress, apoptosis, adipogenesis, and failures in autophagy. In the present work, we aim to present a review of the current knowledge of cadmium toxicity and the cellular response in the liver.
Subject(s)
Cadmium Poisoning , Fatty Liver , Liver Neoplasms , Cadmium/toxicity , Fatty Liver/metabolism , Humans , Liver/metabolism , Liver Neoplasms/metabolism , Male , Metallothionein/metabolism , Oxidative StressABSTRACT
Metabolic factors are the major risk of non-alcoholic fatty liver disease, although other factors may contribute steatosis. Cadmium exposure produces histopathological and molecular changes in liver, which are consistent with steatosis. In the present study, we describe the effect of low cadmium acute treatment on hepatocytes obtained from mice fed with a high cholesterol diet. Our data suggest that hepatocytes with cholesterol overload promote an adaptive response against cadmium-induced acute toxicity by up-regulating anti-apoptotic proteins, managing ROS overproduction, increasing GSH synthesis and MT-II content to avoid protein oxidation. Cadmium treatment increases lipid content in cholesterol-fed mice hepatocytes because of an impaired autophagy process. Our data suggest an essential function of macroautophagy in the regulation of lipid storage induced by Cd on hepatocytes, that implies that alterations in this pathway may be a mechanism that aggravates hepatic steatosis.
Subject(s)
Cadmium Chloride/toxicity , Fatty Liver/etiology , Hepatocytes/drug effects , Hyperlipidemias/etiology , Animals , Apoptosis/drug effects , Autophagy/drug effects , Cholesterol/administration & dosage , Diet/adverse effects , Fatty Liver/chemically induced , Fatty Liver/pathology , Hepatocytes/pathology , Hyperlipidemias/chemically induced , Hyperlipidemias/pathology , Lipid Metabolism/drug effects , Mice , Oxidative Stress/drug effects , Random AllocationABSTRACT
Atmospheric particulate matter with aerodynamic diameter ≤10 µm (PM10) is a risk factor for the development of lung cancer, but cellular pathways are not completely understood. STAT3 is a p21(Waf1/Cip1) transcription factor and is associated with proliferation and cell survival and is upregulated in lung cancer. PM10 exposure induces p21(Waf1/Cip1) expression, which could be related to STAT3 activation. The aims of this work were to investigate whether STAT3 was activated on lung epithelial cells after PM10 exposure and to determine whether or not STAT3 could have an impact on cell cycle distribution and cell survival. Our results showed that PM10 induced STAT3 activation through Src and PKCζ kinases, and it is partially responsible for the p21(Waf1/Cip1) induction that was also observed. Moreover, PM10 induced G1-G0 cell cycle arrest. The inhibition of STAT3 phosphorylation prevented cell cycle arrest and triggered apoptosis. These results suggest that PM10 exposure might activate a survival pathway related to STAT3 activation, similar to what has been described as part of the immune system and apoptosis evasion during tumor promotion and development.
Subject(s)
Apoptosis/drug effects , Cell Cycle Checkpoints/drug effects , Cell Survival/drug effects , Lung Neoplasms/etiology , Lung/drug effects , Particulate Matter/pharmacology , STAT3 Transcription Factor/metabolism , Cell Cycle/drug effects , Cell Division , Cell Line, Tumor , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Humans , Lung/cytology , Lung/metabolism , Lung Neoplasms/metabolism , Particle Size , Protein Kinase C/metabolism , Transcriptional Activation , src-Family Kinases/metabolismABSTRACT
El cadmio (Cd) es un metal que se encuentra principalmente en la corteza terrestre y siempre se presenta en combinación con el zinc. Es ampliamente utilizado en la industria. Se considera un contaminante y es liberado al ambiente como subproducto de la extracción de cobre, hierro y zinc. La exposición al Cd puede producir una variedad de efectos adversos tanto en el humano como en los animales. Una vez absorbido se acumula en el organismo por tiempos largos. Dependiendo de la dosis, fuente y tipo de exposición puede dañar varios órganos como el hígado, riñón, pulmón, hueso, testículos y placenta. Los seres humanos están expuestos al Cd principalmente a través de la ingesta de alimentos, del humo del cigarro, así como del agua y aire contaminados con el metal. La entrada de Cd a las células no es uniforme en todos los sistemas y puede ser mediada por transporte pasivo o activo, o por canales de calcio. Se considera que uno de los mecanismos de toxicidad de este metal es debido, en parte, a las especies reactivas de oxígeno, las cuales pueden actuar como segundos mensajeros y por tanto alterar diferentes vías de señalización. Por todo lo expuesto el objetivo de esta revisión es analizar los efectos del Cd sobre la salud, así como sobre la respuesta celular y molecular.(AU)
Cadmium (Cd) is a metal found in the earth´s crust, always as part of several, mainly zinc-rich, ores. Cd is considered as an environmental pollutant, it is widely used in the industry. It coexists with other metals and its release into the environment is carried out in parallel with the release of copper, iron and zinc. Cd is known to have numerous undesirable effects on health in both humans and animals. Once absorbed, it is effciently retained in the body, where it accumulates throughout life. Depending on the dose, source and type of exposure it could damage several organs as the liver, kidney, lung, bones, testes and placenta. Impor-tant sources of human intoxication are food, cigarette smoke as well as contaminated water and air. Cd cell uptake is not uniform across all systems. This could be mediated by passive or active transport, or via calcium channels. It is known that the toxicity produced by this metal is due, in part to reactive oxygen species, which could act as second messengers that may alter different signaling cascades. The aim of this review is to analyze the effects of Cd on health, as well as on cellular and molecular response.(AU)
ABSTRACT
El cadmio (Cd) es un metal que se encuentra principalmente en la corteza terrestre y siempre se presenta en combinación con el zinc. Es ampliamente utilizado en la industria. Se considera un contaminante y es liberado al ambiente como subproducto de la extracción de cobre, hierro y zinc. La exposición al Cd puede producir una variedad de efectos adversos tanto en el humano como en los animales. Una vez absorbido se acumula en el organismo por tiempos largos. Dependiendo de la dosis, fuente y tipo de exposición puede dañar varios órganos como el hígado, riñón, pulmón, hueso, testículos y placenta. Los seres humanos están expuestos al Cd principalmente a través de la ingesta de alimentos, del humo del cigarro, así como del agua y aire contaminados con el metal. La entrada de Cd a las células no es uniforme en todos los sistemas y puede ser mediada por transporte pasivo o activo, o por canales de calcio. Se considera que uno de los mecanismos de toxicidad de este metal es debido, en parte, a las especies reactivas de oxígeno, las cuales pueden actuar como segundos mensajeros y por tanto alterar diferentes vías de señalización. Por todo lo expuesto el objetivo de esta revisión es analizar los efectos del Cd sobre la salud, así como sobre la respuesta celular y molecular.
Cadmium (Cd) is a metal found in the earth´s crust, always as part of several, mainly zinc-rich, ores. Cd is considered as an environmental pollutant, it is widely used in the industry. It coexists with other metals and its release into the environment is carried out in parallel with the release of copper, iron and zinc. Cd is known to have numerous undesirable effects on health in both humans and animals. Once absorbed, it is effciently retained in the body, where it accumulates throughout life. Depending on the dose, source and type of exposure it could damage several organs as the liver, kidney, lung, bones, testes and placenta. Impor-tant sources of human intoxication are food, cigarette smoke as well as contaminated water and air. Cd cell uptake is not uniform across all systems. This could be mediated by passive or active transport, or via calcium channels. It is known that the toxicity produced by this metal is due, in part to reactive oxygen species, which could act as second messengers that may alter different signaling cascades. The aim of this review is to analyze the effects of Cd on health, as well as on cellular and molecular response.
